3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase EARLY_PHASE1
1
Status
Completed
3
Unknown
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
2
Obesity
1
Hyperandrogenism
1
Interventions
Metformin
35
Clomiphene
11
Letrozole
10
Inositol
7
Triptorelin Pamoate
5
drospirenone and ethinyl estradiol combination
4
Progesterone
4
Folic Acid
4
Ethinyl Estradiol
4
Caloric Restriction
4
drospirenone
3
cetrorelix
3
Spironolactone
3
Estradiol
3
Diet, Mediterranean
3
Diet
3
Cyproterone acetate, ethinyl estradiol drug combination
3
Contraceptives, Oral
3
Acupuncture Therapy
3
adrenosterone
2
Vitamin D
2
Ultrasonography
2
Thioctic Acid
2
Therapeutics
2
Sitagliptin Phosphate
2
Simvastatin
2
Pioglitazone
2
Ovidrel
2
Musculoskeletal Manipulations
2
Hematologic Tests
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Polycystic Ovary Syndrome
×
Ovidrel
×
Clear all
NCT03905603
2023-11-03
SHK001
University of Virginia
Phase EARLY_PHASE1
Unknown
144 enrolled
NCT01421810
2023-10-27
CBS001
University of Virginia
Phase NA
Unknown
80 enrolled